News
GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases Pha ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback